nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain
|
Vázquez-Ucha, Juan Carlos |
|
|
61 |
4 |
p. |
artikel |
2 |
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
|
Gatti, Milo |
|
|
61 |
4 |
p. |
artikel |
3 |
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020–2021)
|
Sader, Helio S. |
|
|
61 |
4 |
p. |
artikel |
4 |
Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review
|
Fazili, T. |
|
|
61 |
4 |
p. |
artikel |
5 |
Development mechanism of resistant population post-exposure to tigecycline in tigecycline-heteroresistant Acinetobacter baumannii strain
|
Jo, Jeongwoo |
|
|
61 |
4 |
p. |
artikel |
6 |
ICEGpa1804, a novel integrative and conjugative element carrying eight resistance genes, identified in Glaesserella parasuis
|
Sun, Huarun |
|
|
61 |
4 |
p. |
artikel |
7 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
61 |
4 |
p. |
artikel |
8 |
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China
|
Yu, Wei |
|
|
61 |
4 |
p. |
artikel |
9 |
National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020
|
Chen, Chih-Hao |
|
|
61 |
4 |
p. |
artikel |
10 |
Pharmacokinetics/pharmacodynamics of ceftobiprole in patients on extracorporeal membrane oxygenation
|
Coppens, Alexandre |
|
|
61 |
4 |
p. |
artikel |
11 |
Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight
|
Chung, Eun Kyoung |
|
|
61 |
4 |
p. |
artikel |
12 |
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis
|
Cao, Yuran |
|
|
61 |
4 |
p. |
artikel |
13 |
Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia
|
Gentry, Chris A. |
|
|
61 |
4 |
p. |
artikel |
14 |
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI
|
Papavramidis, Theodossis |
|
|
61 |
4 |
p. |
artikel |
15 |
Sepsis and antibiotics: When should we deploy a parachute?
|
Einav, Sharon |
|
|
61 |
4 |
p. |
artikel |
16 |
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel
|
Gentry, Chris A. |
|
|
61 |
4 |
p. |
artikel |
17 |
Title Page & Editorial Board
|
|
|
|
61 |
4 |
p. |
artikel |
18 |
Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model
|
van den Born, D. Abraham |
|
|
61 |
4 |
p. |
artikel |
19 |
Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae
|
Pu, Danni |
|
|
61 |
4 |
p. |
artikel |